Artichoke Extract for Health & Longevity - Quick Reference Sheet

Artichoke Extract for Health & Longevity

Created on 07/26/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Artichoke leaf extract is a bitter herbal preparation that gently lowers cholesterol and eases indigestion by boosting bile flow. Its most dependable value is as a low-cost add-on for mildly raised cholesterol and fatty-meal discomfort, with early signals for fatty liver, blood fats, and blood pressure. Main caution: gallstones, a blocked bile duct, or daisy-family allergy. (Full Review)

Protocol

Dose
600–1,800 mg/day
Standardized leaf extract, split into 2–3 doses of 300–640 mg
Standardization
Caffeoylquinic acids or cynarin
e.g. chlorogenic acid 2–5%; avoid generic leaf powder
Timing
With meals
Especially the largest fatty meal, to aid tolerance and digestion
Time to effect
Cholesterol & Triglycerides
6–12 weeks
Measurable on a lipid panel with consistent use
Digestive Relief
Days–2 weeks
Less bloating and fullness after fatty meals
Fatty Liver
8–12 weeks
Improved liver enzymes and ultrasound steatosis grade

Benefits

Contraindications
  • Bile-duct obstruction
  • Asteraceae (daisy/ragweed) allergy
  • Pregnancy and breastfeeding
Key Interactions
  • Gallstones
  • Antidiabetic drugs (metformin, sulfonylureas, insulin)
  • Antihypertensive drugs (ACE inhibitors, calcium-channel blockers)
  • Lipid-lowering therapy (statins, ezetimibe)
  • Other bile-active or hepatically cleared agents (milk thistle, dandelion, turmeric, warfarin)

Risk & Side Effects

  • High: Gastrointestinal symptoms
  • Medium: Allergic reactions; biliary colic with gallstones or bile-duct obstruction
  • Low: Additive hypoglycemia; additive hypotension
  • Speculative: Herb-drug metabolism interactions; uncertain safety in pregnancy and lactation

Monitoring

Marker Target Why
LDL cholesterol < 100 mg/dL (< 80 if high CV risk) Primary marker the extract may lower
Total cholesterol 150–200 mg/dL Overall lipid burden
HDL cholesterol > 55 mg/dL (men), > 60 (women) Extract does not raise HDL, so track the balance
Triglycerides < 90 mg/dL Secondary lipid target and fat-metabolism marker
ALT < 25 U/L (men), < 20 (women) Detects liver-cell stress; tracks the fatty-liver benefit
AST < 25 U/L Complements ALT for liver status
Fasting glucose 75–90 mg/dL Detects additive glucose lowering
hs-CRP < 1.0 mg/L Gauges systemic inflammation and antioxidant effect

Cadence: Baseline, again at 8–12 weeks, then every 6–12 months during continued use

Qualitative Assessment

  • Digestive comfort — less bloating, fullness, or nausea after fatty meals
  • Regularity and stool quality
  • Post-meal energy rather than heaviness or fatigue
  • General appetite and tolerance of rich foods